Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03636503
Title RITUXIMAB + IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Yale New-Haven Hospital New Haven Connecticut 06510 United States Details
Emory University Atlanta Georgia 30322 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University in St. Louis Saint Louis Missouri 63130 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field